Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Adriano Hyeda"'
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background The impact of the COVID-19 pandemic on breast cancer care across Brazilian regions with varying Human Development Index (HDI) levels remains unclear. This study evaluates the pandemic’s effects on screening mammograms, tumor sta
Externí odkaz:
https://doaj.org/article/ec3d27c8c0ba4cc1837e4f7fe959cb89
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background The COVID-19 pandemic has overwhelmed the healthcare systems of many countries and negatively impacted the care of other diseases. Objective To evaluate the trend of screening mammograms, oncological breast surgeries, and breast c
Externí odkaz:
https://doaj.org/article/dd091d9ebfa4423cbc9f8c7f2f8e9ab5
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background The COVID-19 pandemic has overloaded the healthcare systems of many countries and reduced the population’s access to treatment and prevention of other diseases. This study aims to assess whether the COVID-19 pandemic has negativ
Externí odkaz:
https://doaj.org/article/480821b5063748f8b2538b98409c5871
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Immunopreventable diseases are a public health reality in Brazil and worldwide, a reality that is not exclusive to children, but affects the adult population. Objectives Discriminating the total costs of hospitalizations from immu
Externí odkaz:
https://doaj.org/article/b5f4c9218ed9425a895f830d7e5de8a5
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Introduction The occurrence of the immunopreventable diseases in a population global reality. Objective To discriminate the direct costs of the hospitalizations from the immunopreventable diseases in the Unified Health System (SUS), in Brazi
Externí odkaz:
https://doaj.org/article/8810c9bd33ef4bdb97de4853f4f45823
Publikováno v:
Einstein (São Paulo), Vol 15, Iss 2, Pp 192-199
ABSTRACT Objective To conduct an economic analysis of enteral and parenteral diet costs according to the type of disease and outcome (survivors versus deaths). Methods It is a cross-sectional, observational, retrospective study with a qualitative and
Externí odkaz:
https://doaj.org/article/44ae4b07a73b4681bd1ce46d66641593
Publikováno v:
Value in Health Regional Issues. 35:8-12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d06fed2b9fe3464e2d035231cc9312cf
https://doi.org/10.1016/j.vhri.2023.01.004
https://doi.org/10.1016/j.vhri.2023.01.004
ObjectiveTo identify if the COVID-19 pandemic interfered in mammograms and breast cancer biopsy, according to age, in Brazilian public health system.MethodsThis is a retrospective population-based study of total and segmented time series, using the J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c937cdd48eddc834e95c486b0ee2ad0
https://doi.org/10.21203/rs.3.rs-1497469/v1
https://doi.org/10.21203/rs.3.rs-1497469/v1
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Health Services Research, Vol 21, Iss 1, Pp 1-7 (2021)
Introduction The occurrence of the immunopreventable diseases in a population global reality. Objective To discriminate the direct costs of the hospitalizations from the immunopreventable diseases in the Unified Health System (SUS), in Brazil and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c273a525c4481a8dc4e58a564817115
https://pubmed.ncbi.nlm.nih.gov/34706728
https://pubmed.ncbi.nlm.nih.gov/34706728
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Health Services Research, Vol 21, Iss 1, Pp 1-7 (2021)
Background Immunopreventable diseases are a public health reality in Brazil and worldwide, a reality that is not exclusive to children, but affects the adult population. Objectives Discriminating the total costs of hospitalizations from immunoprevent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec30b514289a1a5316de6a17564f435a
https://doi.org/10.21203/rs.3.rs-558143/v1
https://doi.org/10.21203/rs.3.rs-558143/v1